On April 8, WUXI BIO (02269) spent approximately 0.249 billion Hong Kong dollars to repurchase 14 million shares.
WUXI BIO (02269) announced that on April 8, 2025, it spent approximately 0.249 billion Hong Kong dollars to repurchase 14 million shares...
WUXI APPTEC fell in the afternoon, with WUXI APPTEC (02359) down 5.59%. Institutions pointed out that the market is overly concerned about the impact of tariffs on the Sector.
Jinwu Financial News | The WUXI APPTEC system turned to decline in the afternoon. As of the time of writing, WUXI APPTEC (02359) is down 5.59%, WUXI BIO (02269) is down 4.6%, and WUXI XDC (02268) is down 1.34%. WUXI APPTEC (603259) in the A-share market has reached the limit down. BOCOM INTL believes that the market is overly concerned about the impact of tariffs on the Pharmaceutical Sector, and current overselling is severe. The impact of the new round of tariffs on the fundamentals of A/H Pharmaceutical Sector is limited for the following reasons: 1) Pharmaceutical products are currently temporarily exempt from tariffs; 2) Even if tariffs on pharmaceuticals are implemented, there is no direct impact on already completed and pending BD Trades; 3
Biomedical stocks fell across the board, with VIVA BIOTECH (01873) down 27.54%. The impact of China Securities Co.,Ltd.'s tariff policy on the Industry Chain of pharmaceuticals still has uncertainties.
Jinwu Finance | Biomedical stocks fell across the board, with VIVA BIOTECH (01873) down 27.54%, HBM HOLDINGS-B (02142) down 25.43%, CUTIA-B (02487) down 25.13%, Yiming Angke-B (01541) down 24.73%, CSTONE PHARMA-B (02616) down 24.68%, LAEKNA-B (02105) down 24.38%, WUXI BIO (02269) down 24.02%, JACOBIO-B (01167) down 23.72%, and WUXI XDC (02268) down 23.45%. According to multiple sources.
Express News | Shares of WuXi Biologics Down 24%
Trending Stocks Today: CHI KINGSTONE Shoots up 45.8%
Trending Industry Today: WUXI BIO Leads Losses In CRO Stocks
